Coronary artery disease, a leading cause of death in the United States, is commonly treated with arterial stents. Common issues with cobalt chromium (CoCr) and stainless-steel cardiac stents are thrombosis and in-stent restenosis from the growth of neointimal hyperplasia. To address these issues, researchers have investigated alternative stents, such as bioresorbable stents, which could open the artery upon implantation and degrade after re-endothelization of the lumen.